Kliniske undersøgelser ved behandling af tumorinduceret hypercalcæmi Kliniske studier ved malign hypercalcæmi har vist, at ibandronsyres hæmmende virkning på tumorinduceret osteolyse og specifikt på tumorinduceret hypercalcæmi er karakteriseret ved nedsættelse af serum calcium og urin calcium udskillelsen.
Clinical Studies in the Treatment of Tumour-Induced Hypercalcemia Clinical studies in hypercalcaemia of malignancy demonstrated that the inhibitory effect of ibandronic acid on tumour-induced osteolysis, and specifically on tumour-induced hypercalcaemia, is characterised by a decrease in serum calcium and urinary calcium excretion.